Eventide Asset Management - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 1 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q4 2017$2,921,000
-7.9%
463,7000.0%0.15%
-15.6%
Q3 2017$3,172,000
-25.9%
463,700
-22.7%
0.18%
-32.3%
Q2 2017$4,278,000
-22.4%
600,0000.0%0.27%
-27.1%
Q1 2017$5,514,000
+128.0%
600,0000.0%0.36%
+132.5%
Q4 2016$2,418,000
+5.2%
600,0000.0%0.16%
+12.1%
Q3 2016$2,298,000
-10.9%
600,0000.0%0.14%
-11.4%
Q2 2016$2,580,000
+84.7%
600,000
+330.7%
0.16%
+125.7%
Q4 2015$1,397,000
+7.6%
139,300
-19.9%
0.07%
-6.7%
Q3 2015$1,298,000
-90.6%
174,000
-40.0%
0.08%
-89.9%
Q2 2015$13,758,000
+29.5%
290,0000.0%0.74%
-7.0%
Q1 2015$10,626,000
-7.7%
290,0000.0%0.80%
-36.4%
Q4 2014$11,516,000
+91.8%
290,000
-3.6%
1.26%
+50.0%
Q3 2014$6,003,000
+47.9%
300,9000.0%0.84%
+51.8%
Q2 2014$4,059,000
+23.9%
300,9000.0%0.55%
+8.4%
Q1 2014$3,277,000
+150.9%
300,900
+211.5%
0.51%
+26.6%
Q4 2013$1,306,00096,6000.40%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q3 2023
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 354,300$7,068,0002.77%
Opaleye Management Inc. 169,700$3,385,515,0002.64%
Broadfin Capital, LLC 959,247$19,137,0002.01%
Novo Holdings A/S 900,000$17,955,0001.75%
Eventide Asset Management 300,900$6,003,0000.84%
EAM Investors, LLC 152,595$3,044,0000.62%
COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT 497,858$9,932,0000.51%
Granite Point Capital Management, L.P. 40,000$798,0000.40%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 450,191$8,981,0000.33%
TFS CAPITAL LLC 133,070$2,655,0000.23%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders